1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPilot Grants for Rare Disease Research is sponsored by The Wasie Foundation (via University of Minnesota and M Health Fairview's Rare Disease Center of Excellence). The Wasie Foundation supports rare disease research and patients through gifts to institutions like the University of Minnesota.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
New University of Minnesota gift will benefit rare disease research | Pharmacy New University of Minnesota gift will benefit rare disease research Photo credit: University of Minnesota MINNEAPOLIS/ST. PAUL (April 30, 2025) — The University of Minnesota and M Health Fairview’s Rare Disease Center of Excellence recently received $500,000 from the Wasie Foundation to support rare disease research and patients.
The gift will fund small pilot grants for rare disease research and assist families with the costs of genetic testing to identify rare diseases and obtain a diagnosis in a timelier manner.
“This extraordinary commitment from The Wasie Foundation allows us to fast-track innovative research that will help us continue to uncover answers for patients who have waited far too long for a diagnosis,” said Susan Berry, MD, a professor at the University of Minnesota Medical School and physician with M Health Fairview. She is also the director of the Rare Disease Center of Excellence.
“It’s a game changer in helping us close the gap between discovery and care. ” The University of Minnesota Medical School, College of Pharmacy and M Health Fairview Masonic Children’s Hospital’s joint designation as a Rare Disease Center of Excellence recognizes expertise in diagnosing, treating and researching rare diseases.
At the University, researchers are working on everything from basic disease biology, first-in-human studies and clinical trials and biomarker discovery of predictors for outcomes after treatment of rare diseases.
“The Wasie Foundation gift will be particularly impactful for University investigators as it will allow them to initiate early-stage basic and translational research targeted at the development of new therapies for rare disease,” adds Jim Cloyd, PharmD , professor and director of the College of Pharmacy’s Center for Orphan Drug Research .
“Such funding will result in the generation of information and data needed to pursue additional funding beyond the University. Further, the gift will also play an important role in attracting students interested in getting involved in rare disease research.
” “This funding will be crucial in helping families affected by rare diseases get diagnoses, which can lead to a better understanding of these conditions and how to provide the best care,” said Paul Orchard, professor at the U of M Medical School and blood and marrow transplant physician with M Health Fairview.
The Wasie Foundation has supported medical discovery for over 50 years, helping University of Minnesota researchers and clinicians boldly advance innovative, life-changing care for patients with rheumatic and autoimmune disease, as well as epidermolysis bullosa (EB) and schizophrenia. https://www. pharmacy.
umn. edu/news/new-university-minnesota-gift-will-benefit-rare-disease-research Dr. L’Aurelle Johnson selected as 2026 Bush Fellow The University of Minnesota College of Pharmacy is proud to celebrate L’Aurelle Johnson, PhD, associate dean for C. A.
R. E. and associate professor in the Department of Experimental and Clinical Pharmacology, on being named a 2026 Bush Fellow.
Celebrating Medicinal Chemistry's Graduates in the First Half of 2026 Five students graduated from our program in the first half of this calendar year. Ehfazul Haque Impresses at NMCS in Atlanta Ehfazul works with Prof. Gunda Georg on male contraception.
Welcome to the College of Pharmacy Giving to the College of Pharmacy Degrees and Programs Overview Medical Laboratory Sciences Program Occupational Therapy Program Postgraduate Pharmacy Residency Program Postgraduate Pharmacy Residency Program Overview Choosing the University of Minnesota Comprehensive Medication Management Residency Sites & Emphasis Areas Meet Our Current Residents News, Events and Publications A Preventative Look: Evaluating Cardiovascular Risk in Adults ACC 2025: Obesity Management in Heart Failure—Emerging Therapies and Key Pharmacy Practice Considerations Keeping an Eye on GLP-1s: Risk of Age-Related Macular Degeneration Once a Week for Better Control?
Efsitora Challenges Daily Insulin in Type 2 Diabetes RSV Vaccine Now Recommended for At-Risk Adults Aged 50–59 Years Statins for People with HIV: Necessary for Primary Prevention?
Summer Undergraduate Experience Program Online Undergraduate Electives Online Undergraduate Electives Overview PHAR 1001: Orientation to Pharmacy PHAR 1002: Medical Terminology PHAR 1003: Non-Prescription Medications and Self-Care PHAR 1004: Common Prescription Drugs and Diseases Phar 2001: Health sciences calculations and patient safety PHAR 2002: Precision Medicine and Health: Understanding the Personal Genome PHAR 3206: Foundations of Health Literacy Phar 3212: Antimicrobials in Action: Considerations for Patients, Providers, and Policy PHAR 3700/5700: Fundamentals of Pharmacotherapy Phar 3717: Beyond Blood Sugar: Type 2 Diabetes, Stigma, and Controversies in Treatment Phar 3725: Fair Play: Navigating Medication Use and Anti-doping in Sport PHAR 4204W/5204: Drugs and the U.S. Healthcare System PHAR 5201: Applied Medical Terminology PHAR 5310: Topics in Pharmacy Ethics (Pandemics) Undergraduate Electives Overview Pharmacotherapy and Health Systems Minor Continuing Professional Development Departments & Divisions Overview Experimental and Clinical Pharmacology Medical Laboratory Sciences Office of Professional & Clinical Affairs Office of Strategic Initiatives Pharmaceutical Care & Health Systems Pharmacy Practice and Pharmaceutical Sciences Professional Education Division Centers and Institutes Overview Brain Barriers Research Center Center for Clinical and Cognitive Neuropharmacology Center for Forecasting Drug Response Center for Leading Healthcare Change Center for Orphan Drug Research Epilepsy Research and Education Program The Institute for Therapeutics Discovery and Development Institute of Personalized Medicine (IPM) Wulling Center for Innovation & Scholarship in Pharmacy Education Endowed Chairs/Professors Office of the Associate Dean for Research Medical Laboratory Sciences Alumni Occupational Therapy Alumni Publications & Newsletters
According to the current listing, eligibility includes: Review official notice for complete eligibility requirements. Confirm the full requirements in the official notice before applying.
The current listing shows $500,000 (total gift for research and patient assistance). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Pilot Grants for Rare Disease Research is funded by The Wasie Foundation (via University of Minnesota and M Health Fairview's Rare Disease Center of Excellence). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Humana Foundation's first 2026 slate funded 13 nonprofits and five university research teams around senior and veteran emotional health, with awards from $150,000 to $3 million concentrated in Texas, Florida, and Kentucky. A second health equity slate is planned for fall 2026. Here is what the portfolio structure reveals about how this funder decides, and how aging-services and behavioral health organizations should position.
Read articleAnthropic is giving rare-disease researchers and early-stage biotechs up to $50,000 in Claude API credits over six months — not cash, but compute. Here is how the two-track program works, who is eligible, what the credits can and cannot do, and how it fits a fast-growing new category: the compute-as-grant model reshaping how AI-for-science actually gets funded.
Read articleThe NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read article